AskTheDate.com
Back to calendar

Relmada Therapeutics, Inc. (RLMD) Earnings

RLMD reports earnings on Thursday, November 5, 2026

earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.14
Actual EPS: $-0.11
EPS surprise: 44.87%
Company overview
Market Cap$467.2M
PriceUSD 4.38
EPS (TTM)-0.93
52-week high8.00
52-week low1.13
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees17
Buy me a coffee